Abstract:BACKGROUND:An intimidating challenge to transporting drugs into the brain parenchyma is the presence of the blood-brain barrier (BBB). Glucose is an essential nutritional substance for brain function sustenance, which cannot be synthesized by the brain. Its transport primarily depends on the glucose transporters on the brain capillary endothelial cells. In this paper, the brain-targeted properties of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers were compared and evaluated to establish an optimized drug-delivery system. METHODS:Coumarin 6-loaded liposomes (GLU200-LIP, GLU400-LIP, GLU1000-LIP, and GLU2000-LIP) composed of phospholipids and glucose-derived cholesterols were prepared by thin-film dispersion-ultrasound method. The BBB model in vitro was developed to evaluate the transendothelial ability of the different liposomes crossing the BBB. The biodistribution of liposomes in the mice brains was identified by in vivo and ex vivo nearinfrared fluorescence imaging and confocal laser scanning microscopy and further analyzed quantitatively by high-performance liquid chromatography. RESULTS:Glucose-derived cholesterols were synthesized and identified, and coumarin 6-loaded liposomes were prepared successfully. The particle sizes of the four types of glucose-modified liposomes were around or smaller than 100 nm with a polydispersity index less than 0.300. GLU400-LIP, GLU1000-LIP, and GLU2000-LIP achieved higher cumulative cleared volumes on BBB model in vitro after 6 hours compared with GLU200-LIP (P < 0.05) and were significantly higher than that of the conventional liposome (P < 0.001). The qualitative and quantitative biodistribution results in the mice showed that the accumulation of GLU1000-LIP in the brain was the highest among all the groups (P < 0.01 versus LIP). CONCLUSION:The data indicated that GLU400-LIP, GLU1000-LIP, and GLU2000-LIP all possess the potential of brain targeting, among which GLU1000-LIP, as a promising drug-delivery system, exhibited the strongest brain delivery capacity.

Liposome Formulated with TAT-modified Cholesterol for Improving Brain Delivery and Therapeutic Efficacy on Brain Glioma in Animals

Transferrin and Cell-Penetrating Peptide Dual-Functioned Liposome for Targeted Drug Delivery to Glioma.

Cell Penetrating Peptide TAT and Brain Tumor Targeting Peptide T7 Dual Modified Liposome Preparation and in Vitro Targeting Evaluation

Comparison of four different peptides to enhance accumulation of liposomes into the brain.

A Dual-Mediated Liposomal Drug Delivery System Targeting the Brain: Rational Construction, Integrity Evaluation Across the Blood-Brain Barrier, and the Transporting Mechanism to Glioma Cells

Enhanced Glioma Targeting and Penetration by Dual-Targeting Liposome Co-Modified with T7 and TAT.

Design, Synthesis and Biological Evaluation for Docetaxel- Loaded Brain Targeting Liposome with "Lock-In'' Function

Dual-targeting for Brain-Specific Liposomes Drug Delivery System: Synthesis and Preliminary Evaluation

Enhancing Glioma Treatment by Using Novel Cryptotanshinone-Loaded Nano-Liposomes

In Vitro and in Vivo Investigation of Glucose-Mediated Brain-Targeting Liposomes.

Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles

Brain-targeted Drug Delivery by in Vivo Functionalized Liposome with Stable D-peptide Ligand.

Enhanced Efficacy of Functionalized Epirubicin Liposomes in Treating Brain Glioma-Bearing Rats.

Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.

Glioma Targeted Delivery Strategy of Doxorubicin-Loaded Liposomes by Dual-Ligand Modification

Lactoferrin-modified Procationic Liposomes As a Novel Drug Carrier for Brain Delivery.

Blood–brain Barrier Transport of Tat Peptide and Polyethylene Glycol Decorated Gelatin–siloxane Nanoparticle

Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals.

Lipid Vesicles Containing Transferrin Receptor Binding Peptide TfR-T12 and Octa-Arginine Conjugate Stearyl-R8 Efficiently Treat Brain Glioma along with Glioma Stem Cells

Enhanced Brain Targeting of Tegafur Using Novel Lactyl Cholesterol Liposome As a Carrier

Targeted Delivery of Cargoes into A Murine Solid Tumor by A Cell-Penetrating Peptide and Cleavable Poly(Ethylene Glycol) Comodified Liposomal Delivery System Via Systemic Administration